News

Jon Epstein Serves as Keynote Speaker at Life Sciences Future – Biopharm, Discusses CAR-T and the Future of Healthcare

October 25, 2022 | Posted in Events

During the session, Epstein presented his research, which involves using in vivo CAR-T cell therapy to target cardiac fibrosis. He also discussed the future of healthcare.

Penn spinout and I-Corps participant NeuroFlow raises $25 million growth round, doubles headcount and expands into Center City office

October 21, 2022 | Posted in I-Corps, Startups

The funding will help Neuroflow, a Philadelphia-based mental health startup, make greater investments in research and development, expand its technology platform and increase headcount.

Philadelphia gene therapy company Passage Bio names former Novartis executive as new CEO

October 11, 2022 | Posted in Startups

Philadelphia gene therapy company Passage Bio appointed Dr. Will Chou, former Novartis executive, as its new CEO.

A decade of advancing working dogs for the greater good

October 8, 2022 | Posted in Penn Vet

Penn Spinout and I-Corps Participant Innervace Raises $40 Million for Parkinson’s Disease Research

October 5, 2022 | Posted in I-Corps, PCI Ventures, Startups

The funds will allow Innervace to advance their platform and lead asset in Parkinson’s disease, which aims to reconstruct the neuronal circuitry that is lost in Parkinson's patients.

The Power of Pennovation Works: Research and Development

October 3, 2022 | Posted in Pennovation Works, Success Story

In November, in recognition of the 5th year anniversary of Pennovation Works, the Pennovation Center hosted The Power of Pennovation Works: Research and Development panel.

Philadelphia Ranks Second in New Study Comparing U.S. Cell and Gene Therapy Hubs

September 29, 2022 | Posted in Industry Trends

Philadelphia ranks second in a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories.

Penn Spinout Verismo Therapeutics Receives FDA Clearance of Investigational New Drug Application for SynKIR-110™, a KIR-CAR T Cell Immunotherapy Candidate

September 27, 2022 | Posted in Startups

Verismo plans to begin enrolling patients in the first quarter of 2023 at the initial clinical site, the Hospital of the University of Pennsylvania.

Penn Ranks Number 15 on Report of Top 100 Worldwide Universities Granted U.S. Utility Patents in 2021

September 26, 2022 | Posted in Awards, Penn in the News

The National Academy of Inventors & the Intellectual Property Owners Association ranked Penn in the Top 100 Worldwide Universities Granted U.S. Utility Patents in 2021.

Weissman Lab is Working on New Type of Vaccines to Protect Against All Coronaviruses

September 23, 2022 | Posted in School of Medicine

The Weissman Lab is working towards developing vaccines that not only target multiple COVID variants, but also multiple types of coronaviruses.